Ahmed M Abu El-Asrar Selected Research

Ahmed M Abu El-Asrar Research Topics

Disease

50	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2022 - 08/2006
29	Epiretinal Membrane (Epiretinal Membranes) 01/2022 - 09/2006
28	Inflammation (Inflammations) 04/2022 - 04/2007
23	Uveitis 09/2022 - 09/2004
11	Uveomeningoencephalitic Syndrome (Vogt Koyanagi Harada Syndrome) 09/2022 - 10/2010
9	Hypoxia (Hypoxemia) 01/2022 - 06/2007
8	Retinal Detachment (Retinal Detachments) 12/2021 - 06/2005
6	Macular Edema 03/2021 - 06/2005
6	Proliferative Vitreoretinopathy 02/2018 - 09/2006
5	Fibrosis (Cirrhosis) 12/2014 - 03/2012
4	Tuberculosis (Tuberculoses) 06/2021 - 12/2008
4	Necrosis 01/2020 - 01/2010
4	Cataract (Cataracts) 01/2019 - 04/2010
3	Sarcoidosis (Schaumann Disease) 04/2020 - 01/2016
3	Glaucoma 02/2015 - 10/2009
2	Neoplasms (Cancer) 10/2021 - 01/2014
2	Ischemia 10/2020 - 06/2010
2	Vitreous Hemorrhage 10/2020 - 08/2006
2	Wounds and Injuries (Trauma) 05/2018 - 06/2014
2	Infections 01/2018 - 10/2010
2	Hemorrhage 08/2013 - 08/2006
2	Allergic Conjunctivitis (Giant Papillary Conjunctivitis) 11/2003 - 01/2003
1	B-Cell Lymphoma (Lymphoma, B Cell) 08/2022
1	Chickenpox 08/2022
1	Herpes Zoster 08/2022
1	Retinitis 08/2022
1	Breast Neoplasms (Breast Cancer) 10/2021
1	Optic Neuritis (Retrobulbar Neuritis) 03/2021
1	Multiple Sclerosis 03/2021
1	Vitiligo 01/2021

Drug/Important Bio-Agent (IBA)

23	Retinaldehyde (Retinal)IBA 09/2022 - 06/2005
19	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021 - 06/2007
18	EnzymesIBA 01/2020 - 09/2004
15	ImmunosorbentsIBA 01/2020 - 09/2004
12	Adrenal Cortex Hormones (Corticosteroids)IBA 04/2022 - 04/2007
11	CytokinesIBA 04/2020 - 01/2012
11	Proteins (Proteins, Gene)FDA Link 02/2019 - 06/2007
10	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2013
9	ChemokinesIBA 01/2020 - 01/2003
8	HMGB1 Protein (HMG1)IBA 10/2019 - 01/2012
6	Mycophenolic Acid (Cellcept)FDA LinkGeneric 03/2021 - 10/2010
6	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2018 - 01/2010
5	Oxygen (Dioxygen)IBA 09/2022 - 01/2014
5	cobaltous chloride (cobalt(II)chloride)IBA 05/2021 - 12/2016
5	Matrix Metalloproteinases (MMPs)IBA 02/2018 - 08/2006
5	Matrix Metalloproteinase 9 (Gelatinase B)IBA 01/2018 - 08/2006
3	Indocyanine Green (Cardio-Green)FDA LinkGeneric 12/2021 - 09/2016
3	Fluorescein (Funduscein)FDA LinkGeneric 03/2021 - 10/2009
3	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 12/2016
3	Interleukin-6 (Interleukin 6)IBA 06/2018 - 01/2013
3	cadherin 5IBA 03/2015 - 01/2012
3	lysophosphatidic acidIBA 12/2014 - 03/2012
3	Infliximab (Remicade)FDA Link 09/2014 - 06/2005
3	Chemokine ReceptorsIBA 06/2010 - 09/2006
2	Monoclonal AntibodiesIBA 04/2022 - 01/2021
2	Rituximab (Mabthera)FDA Link 04/2022 - 01/2021
2	Reactive Oxygen Species (Oxygen Radicals)IBA 05/2021 - 02/2015
2	Tissue Inhibitor of Metalloproteinase-3IBA 01/2021 - 02/2018
2	Streptozocin (Streptozotocin)FDA Link 01/2021 - 11/2014
2	Caspase 3 (Caspase-3)IBA 01/2021 - 02/2015
2	Interleukin-11 (Interleukin 11)IBA 05/2020 - 04/2020
2	Metalloproteases (Metalloproteinases)IBA 01/2020 - 02/2018
2	InterleukinsIBA 08/2019 - 08/2012
2	Interleukin-10 (Interleukin 10)IBA 08/2019 - 08/2012
2	Tuberculin (PPD)IBA 02/2019 - 12/2008
2	OsteoprotegerinIBA 01/2018 - 01/2017
2	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2017 - 01/2013
2	heparanaseIBA 01/2016 - 12/2015
2	Syndecan-1 (Syndecan 1)IBA 12/2015 - 01/2014
2	Cadherins (E-Cadherin)IBA 03/2015 - 01/2012
2	EndoglinIBA 03/2015 - 01/2012
2	Receptor for Advanced Glycation End ProductsIBA 02/2015 - 01/2013
2	Mitomycin (Mitomycin-C)FDA LinkGeneric 02/2015 - 10/2009
2	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 01/2015 - 01/2013
2	OsteopontinIBA 01/2014 - 01/2012
2	ThrombospondinsIBA 08/2013 - 05/2013
2	acylglycerol kinaseIBA 06/2013 - 03/2012
2	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2013 - 01/2013
2	InterferonsIBA 08/2012 - 11/2003
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2012 - 06/2010
2	pigment epithelium-derived factorIBA 01/2012 - 06/2007
2	Connective Tissue Growth FactorIBA 01/2012 - 02/2007
2	Triamcinolone (Aristocort)FDA Link 04/2011 - 04/2010
2	Triamcinolone Acetonide (Azmacort)FDA LinkGeneric 04/2011 - 04/2010
2	Chemotactic FactorsIBA 09/2004 - 11/2003
1	Acyclovir (Aciclovir)FDA LinkGeneric 08/2022
1	Ganciclovir (Cytovene)FDA LinkGeneric 08/2022
1	Proprotein Convertases (Pro-Opiomelanocortin Converting Enzyme)IBA 01/2022
1	FurinIBA 01/2022
1	matrigelIBA 10/2021
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 10/2021
1	NADPH Oxidases (NAD(P)H oxidase)IBA 05/2021

Therapy/Procedure

18	Therapeutics 08/2022 - 03/2005
6	Traction 06/2014 - 06/2005
4	Vitrectomy 01/2013 - 08/2006
2	Light Coagulation 04/2011 - 04/2010
2	Lasers (Laser) 04/2011 - 04/2010
1	Immunotherapy 08/2022
1	Cautery 10/2021
1	Immunomodulation 01/2021